Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
enVVeno Medical ( (NVNO) ) has shared an update.
On October 7, 2025, enVVeno Medical Corporation was notified by Nasdaq that its common stock had fallen below the $1.00 per share minimum bid price requirement for 30 consecutive business days, putting it out of compliance with Nasdaq’s listing rules. The company has until April 6, 2026, to regain compliance by ensuring its stock closes at or above $1.00 for at least 10 consecutive trading days. Failure to comply could lead to delisting, though the company may qualify for an additional compliance period and has the right to appeal any delisting decision.
Spark’s Take on NVNO Stock
According to Spark, TipRanks’ AI Analyst, NVNO is a Neutral.
enVVeno Medical’s overall stock score is influenced by its robust technical performance, which is somewhat overshadowed by challenging financial metrics. The company faces significant profitability issues, as reflected by its negative income and cash flow figures, despite having a stable balance sheet. While technical indicators show strong upward momentum, valuation concerns due to a negative P/E ratio and lack of dividends weigh on the score.
To see Spark’s full report on NVNO stock, click here.
More about enVVeno Medical
Average Trading Volume: 954,336
Technical Sentiment Signal: Sell
Current Market Cap: $18.43M
Find detailed analytics on NVNO stock on TipRanks’ Stock Analysis page.